Dividend
-
-
-
-
-
-
-
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
-
-
-
-
-
-
-
Kane Biotech Restarts Commercial Activities and Strengthens North American Management
-
-
-
-
-
-
-
Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray
-
-
-
-
-
-
-
Kane Biotech Announces First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel
-
-
-
-
-
-
-
Kane Biotech to Participate in a Multinational Corporate Collaboration Project
-
-
-
-
-
-
-
Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound Gel
-
451,169 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

